Dose daily

Pfizer’s Strategic Exit from BioNTech Post Covid Vaccine Windfall

By: Dose Daily News Bureau

Date:

Share post:

Previous article
MoHFW Officially Notifies the 2025 Recruitment Rules for Drug Inspector Posts Under CDSCO
Next article
UGC’s Yuvamanthan Initiative – Advisory Issued for Strict Implementation of the POSH Act
Dose Daily News Bureau
Dose Daily News Bureauhttps://dosedailynews.com/

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Related articles

Breaking News

Novo Nordisk Hit by an IT Security Breach: Pharma Giant Confronts Cyber Threats

Novo Nordisk (Novo Nordisk A/S) the Danish multinational pharmaceutical major, earlier this week announced that the company had identified an IT security incident involving unauthorised access to...
Breaking News

Hair Color Brands Must Meet New CDSCO Regulations Under Latest Order

The Central Drugs Standard Control Organisation (CDSCO), under the Directorate General of Health Services, Government of India, has...
Breaking News

FDA Grants Accelerated Approval to Sanofi’s Tzield® for Pediatric Stage 3 Type 1 Diabetes

The U.S. Food and Drug Administration has granted accelerated approval to Sanofi's Tzield® (teplizumab-mzwv) for children aged 8 to...
Breaking News

​The FDA has outlined its updated strategy for generic drug oversight

The U.S. Food and Drug Administration (FDA) announced its modernized framework for generic drug oversight, highlighting a dual...